Skip to main content

Table 4 Meta-analysis of active tuberculosis prevalence and Mycobacterium tuberculosis infection prevalence at baseline among close contacts

From: Declining incidence rate of tuberculosis among close contacts in five years post-exposure: a systematic review and meta-analysis

Subgroups

No. of included studiesa

Summarized prevalence of active TBb (95% CI)

Heterogeneity

I2

P for Q test

Total

18

2.68% (2.02%-3.35%)

95.67%

 < 0.0001

From high TB burden countriese

4

5.55% (2.98%-8.11%)

85.90%

 < 0.0001

From other countriese

14

2.16% (1.49%-2.82%)

95.89%

 < 0.0001

Subgroups

No. of included studiesc

Summarized prevalence of MTB infection (95% CI)

Heterogeneity

I2

P for Q test

Total

20

46.30% (37.18%-55.41%)d

99.58%

 < 0.0001

Testing by TST

18

48.37% (38.58%-58.16%)

99.61%

 < 0.0001

Testing by IGRA

6

41.24% (21.06%-61.42%)

99.67%

 < 0.0001

Index cases were smear + 

5

53.94% (41.76%-66.12%)

98.90%

 < 0.0001

From high TB burden countriese

6

52.80% (38.62%-66.98%)

98.99%

 < 0.0001

From other countriese

14

43.51% (32.32%-54.71%)

99.65%

 < 0.0001

  1. Abbreviation CI Confidence interval, IGRA Interferon gamma release assay, MTB Mycobacterium tuberculosis, TB Tuberculosis, TST Tuberculin skin test
  2. aOf the included 31 studies, 18 of them investigating the baseline active tuberculosis (TB) prevalence were included in summarized active TB prevalence analysis
  3. bMost articles’ active TB prevalence at baseline among close contacts included coprevalent disease which was defined as confirmed or unconfirmed TB identified at baseline or within 3 months post-exposure
  4. cOf the included 31 studies, 20 of them investigating the baseline Mycobacterium tuberculosis infection (MTB) infection prevalence were included in Summarized MTB infection prevalence analysis. Most studies’ MTB infection was defined as a tuberculin skin-test induration response of ≥ 10 mm in adults or ≥ 5 mm in children. Several articles defined as both TST and IGRA
  5. dMTB infection was defined as TST ≥ 10 mm in adults or ≥ 5 mm in children other than only IGRA were used [26, 27]
  6. eHigh TB burden countries were defined by World Health Organization global TB report 2022 (Geneva: World Health Organization, 2022) [3]